Naloxone Hydrochloride Injection, Solution
Product Images NDC 51662-1385

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 51662-1385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Labeling (Box Labeling)

Carton label for Naloxone Hydrochloride Injection, USP 0.4 mg/mL in a 10 mL multiple-dose Riptrop vial. The label includes dosage form and strength, NDC 0409-1219-01, route information for intravenous, intramuscular, or subcutaneous use, preservative details, storage instructions, and the manufacturer Hospira, Inc., Lake Forest, IL 60045 USA.*

FDA Label Image

Logo (How Supplied Logo)

FDA Label Image

How Supplied (How Supplied)

A data table showing NDC numbers, packaging descriptions, and concentrations for naloxone hydrochloride injection solution. It includes single-dose fliptop vials in cartons of 10 at 0.4 mg/mL and multi-dose fliptop vials in cases of 25 cartons at the same concentration.*

FDA Label Image

Serialized Carton Labeling (Serialized Box Labeling)

Packaging label of Naloxone Hydrochloride Injection, USP 0.4 mg/mL in a 10 mL multiple-dose fliptop vial. The label shows the product name in red, strength, dosage form, and manufacturer Hospira, Inc., Lake Forest, IL. It includes storage instructions and a barcode label with distribution details by HF Acquisition Co LLC.*

FDA Label Image

Structure (Structure)

Chemical structure of naloxone hydrochloride showing its molecular arrangement including hydroxy, ketone groups, and hydrochloride salt.*

FDA Label Image

Vila Labeling (Vial Labeling)

Label for Naloxone Hydrochloride injection, USP 0.4 mg/mL, 10 mL multiple-dose vial. The label states it is for intramuscular, intravenous, or subcutaneous use and is a prescription drug. Manufactured by Hospira, Inc., Lake Forest, IL, USA. Additional text includes storage instructions and notes on sterility and pH adjustment.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.